These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Corticotropin-releasing hormone skin signaling is receptor-mediated and is predominant in the sebaceous glands. Krause K; Schnitger A; Fimmel S; Glass E; Zouboulis CC Horm Metab Res; 2007 Feb; 39(2):166-70. PubMed ID: 17326013 [TBL] [Abstract][Full Text] [Related]
9. Corticotropin-releasing hormone heterogeneous nuclear RNA (hnRNA) and immunoreactivity are induced in extrahypothalamic brain sites by kainic-acid-induced seizures and are modulated by estrogen. Foradori CD; Lund TD; Nagahara AH; Koenig JI; Handa RJ Brain Res; 2007 Aug; 1164():44-54. PubMed ID: 17631870 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of pentylenetetrazole-induced seizures by Shigella dysenteriae in LPS-resistant C3H/HeJ mice: role of the host response. Yuhas Y; Nofech-Mozes Y; Weizman A; Ashkenazi S Med Microbiol Immunol; 2002 Mar; 190(4):173-8. PubMed ID: 12005330 [TBL] [Abstract][Full Text] [Related]
11. Corticotropin releasing hormone receptor alterations elicited by acute and chronic unpredictable stressor challenges in stressor-susceptible and resilient strains of mice. Anisman H; Prakash P; Merali Z; Poulter MO Behav Brain Res; 2007 Aug; 181(2):180-90. PubMed ID: 17517441 [TBL] [Abstract][Full Text] [Related]
12. Alleviation of the effects of endotoxin exposure on behavior and hippocampal IL-1beta by a selective non-peptide antagonist of corticotropin-releasing factor receptors. Kohman RA; Tarr AJ; Sparkman NL; Day CE; Paquet A; Akkaraju GR; Boehm GW Brain Behav Immun; 2007 Aug; 21(6):824-35. PubMed ID: 17339098 [TBL] [Abstract][Full Text] [Related]
13. Evidence for the involvement of the adenosine A(2A) receptor in the lowered susceptibility to pentylenetetrazol-induced seizures produced in mice by long-term treatment with caffeine. El Yacoubi M; Ledent C; Parmentier M; Costentin J; Vaugeois JM Neuropharmacology; 2008 Jul; 55(1):35-40. PubMed ID: 18486156 [TBL] [Abstract][Full Text] [Related]
15. Expression of type 1 corticotropin-releasing hormone (CRH) receptor mRNA in the hypothalamic paraventricular nucleus following restraint stress in CRH-deficient mice. Makino S; Tanaka Y; Nazarloo HP; Noguchi T; Nishimura K; Hashimoto K Brain Res; 2005 Jun; 1048(1-2):131-7. PubMed ID: 15919058 [TBL] [Abstract][Full Text] [Related]
16. Mineralocorticoid receptors mediate the enhancing effects of corticosterone on convulsion susceptibility in mice. Roberts AJ; Keith LD J Pharmacol Exp Ther; 1994 Aug; 270(2):505-11. PubMed ID: 8071844 [TBL] [Abstract][Full Text] [Related]
17. Corticotropin-releasing hormone and urocortin: redundant or distinctive functions? Gysling K; Forray MI; Haeger P; Daza C; Rojas R Brain Res Brain Res Rev; 2004 Dec; 47(1-3):116-25. PubMed ID: 15572167 [TBL] [Abstract][Full Text] [Related]
18. The role of central corticotropin-releasing hormone in the anorexic and endocrine effects of the bacterial T cell superantigen, Staphylococcal enterotoxin A. Kaneta T; Kusnecov AW Brain Behav Immun; 2005 Mar; 19(2):138-46. PubMed ID: 15664786 [TBL] [Abstract][Full Text] [Related]
19. Mirtazapine does not affect pentylenetetrazole- and maximal electroconvulsive shock-induced seizures in mice. Yilmaz I; Sezer Z; Kayir H; Uzbay TI Epilepsy Behav; 2007 Aug; 11(1):1-5. PubMed ID: 17517536 [TBL] [Abstract][Full Text] [Related]
20. Lateral hypothalamus orexinergic system modulates the stress effect on pentylenetetrazol induced seizures through corticotropin releasing hormone receptor type 1. Mokhtarpour M; Elahdadi Salmani M; Lashkarbolouki T; Abrari K; Goudarzi I Neuropharmacology; 2016 Nov; 110(Pt A):15-24. PubMed ID: 27395784 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]